QELBREE 100 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 100 mg/1

QELBREE (viloxazine hydrochloride) is an extended-release capsule used for managing certain mental health conditions. This medication is designed to provide sustained relief and is available in a 100 mg strength.

Strength

100 mg/1

Pack Size

7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. It works by affecting certain chemicals in the brain that may be unbalanced, helping to improve focus and reduce impulsivity. This medication is part of a broader category of drugs known as selective norepinephrine reuptake inhibitors (SNRIs).

Side Effects

Common effects of QELBREE may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users may experience headaches or dizziness, especially when first starting the medication. These effects are generally mild and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

QELBREE should be handled with care, stored at room temperature, and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the capsules, as they are designed for extended release.

Avoid Interactions

QELBREE may interact with other medications, including those that affect liver enzymes, such as certain antidepressants and antibiotics. It is also advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

QELBREE is used for the treatment of ADHD in adults. It helps improve focus and reduce impulsivity by affecting certain chemicals in the brain.

QELBREE should be taken orally, exactly as prescribed by a healthcare professional. The capsules should not be crushed or chewed.

Common side effects may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users may also experience headaches or dizziness.

QELBREE may interact with other medications, especially those that affect liver enzymes. Always inform your healthcare provider about all medications you are taking.

It is advisable to avoid alcohol while taking QELBREE, as it can increase the risk of side effects.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.